WOOJUNG BIO, Inc. (KOSDAQ:215380) Shares Fly 34% But Investors Aren't Buying For Growth
Jan 29
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Life Sciences Industry Analysis
UpdatedFeb 24, 2026
DataAggregated Company Financials
Companies27
- 7D1.5%
- 3M4.7%
- 1Y7.0%
- YTD2.9%
In the last week, the Life Sciences industry is up 1.5%, with Samsung BiologicsLtd up 1.0%. During this same period, the BioInfra underperformed, falling 5.9%. In the last 12 months, the industry was up 7.0%. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the South Korean Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 24 Feb 2026 | ₩97.0t | ₩5.4t | ₩1.5t | 17.6x | 64.1x | 17.9x |
| Thu, 22 Jan 2026 | ₩101.2t | ₩6.4t | ₩1.5t | 15.5x | 67.7x | 15.9x |
| Sat, 20 Dec 2025 | ₩96.3t | ₩6.4t | ₩1.5t | 17.2x | 64.4x | 15.1x |
| Mon, 17 Nov 2025 | ₩103.8t | ₩5.8t | ₩1.2t | 17.3x | 87x | 17.8x |
| Wed, 15 Oct 2025 | ₩87.7t | ₩5.8t | ₩1.2t | 15.4x | 73.9x | 15x |
| Fri, 12 Sep 2025 | ₩89.3t | ₩5.8t | ₩1.2t | 14.6x | 75.3x | 15.3x |
| Sun, 10 Aug 2025 | ₩87.8t | ₩5.7t | ₩1.2t | 16.5x | 71.7x | 15.5x |
| Tue, 08 Jul 2025 | ₩84.6t | ₩5.6t | ₩1.2t | 15.3x | 68.7x | 15.1x |
| Thu, 05 Jun 2025 | ₩83.7t | ₩5.6t | ₩1.2t | 14.8x | 67.9x | 14.9x |
| Sat, 03 May 2025 | ₩87.4t | ₩5.2t | ₩1.0t | 18.2x | 85.3x | 16.7x |
| Mon, 31 Mar 2025 | ₩82.5t | ₩5.2t | ₩1.0t | 18x | 81.2x | 15.8x |
| Wed, 26 Feb 2025 | ₩92.5t | ₩5.0t | ₩965.6b | 12.9x | 95.9x | 18.5x |
| Fri, 24 Jan 2025 | ₩83.9t | ₩5.0t | ₩965.6b | 12.7x | 86.9x | 16.7x |
| Sun, 22 Dec 2024 | ₩74.3t | ₩5.0t | ₩965.6b | 12.5x | 77x | 14.8x |
| Tue, 19 Nov 2024 | ₩74.1t | ₩4.8t | ₩885.3b | 12.5x | 83.7x | 15.3x |
| Thu, 17 Oct 2024 | ₩84.6t | ₩4.8t | ₩885.3b | 14x | 95.6x | 17.4x |
| Sat, 14 Sep 2024 | ₩77.4t | ₩4.8t | ₩885.3b | 14x | 87.5x | 16x |
| Mon, 12 Aug 2024 | ₩75.2t | ₩4.5t | ₩731.7b | 15.3x | 102.8x | 16.6x |
| Wed, 10 Jul 2024 | ₩63.6t | ₩4.5t | ₩731.7b | 18.8x | 87x | 14x |
| Fri, 07 Jun 2024 | ₩59.9t | ₩4.6t | ₩689.6b | 19.4x | 86.8x | 13x |
| Sun, 05 May 2024 | ₩60.7t | ₩4.4t | ₩635.1b | 19.8x | 95.6x | 13.9x |
| Tue, 02 Apr 2024 | ₩65.2t | ₩4.7t | ₩656.9b | 19.6x | 99.2x | 13.9x |
| Thu, 29 Feb 2024 | ₩62.7t | ₩4.5t | ₩714.4b | 34.7x | 87.8x | 13.9x |
| Sat, 27 Jan 2024 | ₩60.8t | ₩4.5t | ₩714.4b | 34.5x | 85.1x | 13.4x |
| Mon, 25 Dec 2023 | ₩57.1t | ₩4.5t | ₩721.5b | 30.9x | 79.2x | 12.6x |
| Wed, 22 Nov 2023 | ₩56.9t | ₩4.4t | ₩647.2b | 23.3x | 87.9x | 12.9x |
| Fri, 20 Oct 2023 | ₩55.8t | ₩4.4t | ₩660.9b | 29.2x | 84.4x | 12.7x |
| Sun, 17 Sep 2023 | ₩58.3t | ₩4.4t | ₩660.9b | 28.9x | 88.2x | 13.3x |
| Tue, 15 Aug 2023 | ₩62.5t | ₩4.2t | ₩673.4b | 29.2x | 92.8x | 14.9x |
| Thu, 13 Jul 2023 | ₩57.0t | ₩4.2t | ₩673.4b | 29.4x | 84.6x | 13.6x |
| Sat, 10 Jun 2023 | ₩62.3t | ₩4.2t | ₩666.5b | 31.4x | 93.5x | 14.7x |
| Mon, 08 May 2023 | ₩62.4t | ₩4.1t | ₩626.3b | 28x | 99.6x | 15.3x |
| Wed, 05 Apr 2023 | ₩61.4t | ₩4.1t | ₩626.3b | 28.9x | 98x | 15x |
| Fri, 03 Mar 2023 | ₩60.3t | ₩3.5t | ₩427.8b | 21.2x | 140.9x | 17.3x |
Price to Earnings Ratio
140.9x
Current Industry PE
- Investors are pessimistic on the South Korean Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 64.1x which is lower than its 3-year average PE of 84.9x.
- The 3-year average PS ratio of 15.0x is lower than the industry's current PS ratio of 17.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have grown 52% per year over the last three years.
- Revenues for these companies have grown 16% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | 5.90% | |
| Healthcare | 4.28% | |
| Life Sciences | 1.47% | |
| Clinical Research and Equipment | 1.47% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A207940 Samsung BiologicsLtd | ₩1.73m | 1.0% +₩786.9b | -4.6% | PE49.5x | |
| A087010 Peptron | ₩271.50k | 11.3% +₩641.2b | 204.0% | PS1022.4x | |
| A187660 Hyundai ADM Bio | ₩15.67k | 112.3% +₩454.0b | 729.1% | PS88.1x | |
| A141080 LigaChem Biosciences | ₩183.10k | 3.7% +₩236.6b | 61.3% | PS41.9x | |
| A039860 NanoEntek | ₩7.67k | 68.2% +₩118.5b | 107.9% | PE109x |
